Mizuho Securities Upgrades Myriad Genetics (MYGN) to Buy
Mizuho Securities upgraded Myriad Genetics (NASDAQ: MYGN) from Neutral to Buy with a price target of $34.00 (from $27.00).
For an analyst ratings summary and ratings history on Myriad Genetics click here. For more ratings news on Myriad Genetics click here.
Shares of Myriad Genetics closed at $28.30 yesterday, with a 52 week range of $22.02-$31.80.
For an analyst ratings summary and ratings history on Myriad Genetics click here. For more ratings news on Myriad Genetics click here.
Shares of Myriad Genetics closed at $28.30 yesterday, with a 52 week range of $22.02-$31.80.